To investigate the potential of the plasma Hex activity to stratify CRC patient risk in terms of mortality, total Hex activity was measured in plasma from a large cohort of 380 plasma samples comprising CRC patients for which 5-year survival data were available and healthy donors (Fig. 4D). This evidence concerns the gene HHEX and colorectal carcinoma.